Nine-year-old Jizaiah had been battling acute lymphoblastic leukemia (ALL) since he was four. Jizaiah underwent chemotherapy and radiation treatment, and then a bone marrow transplant. One year after transplant, his family learned the leukemia had returned.
“It was devastating,” recalls Lillian, Jizaiah’s mother.
However, the physicians at the Children’s Cancer Institute at Hackensack Meridian Health were able to give Jizaiah a new option — CAR-T Cell Therapy. This promising new protocol for children with recurrent or refractory disease, utilizes immunotherapy, harnessing a patient’s immune system to fight the disease. It has a very high success rate, and is only offered currently in select institutions nationwide — including Hackensack University Medical Center.
Since the treatment in March, a bone marrow biopsy and spinal tap have shown no evidence of cancer in Jizaiah, which indicates he is in remission.